Published in Stem Cells Dev on July 03, 2014
Manufacturing of dental pulp cell-based products from human third molars: current strategies and future investigations. Front Physiol (2015) 0.76
Characterization and angiogenic potential of human neonatal and infant thymus mesenchymal stromal cells. Stem Cells Transl Med (2015) 0.75
Poly-L-lysine Prevents Senescence and Augments Growth in Culturing Mesenchymal Stem Cells Ex Vivo. Biomed Res Int (2016) 0.75
Migration of Adipose-derived Mesenchymal Stem Cells Stably Expressing Chondroitinase ABC In vitro. Chin Med J (Engl) (2016) 0.75
Differentiation potential of human adipose tissue derived stem cells into photoreceptors through explants culture and enzyme methods. Int J Ophthalmol (2017) 0.75
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) 37.55
Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng (2001) 20.65
Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood (2004) 13.79
Stem cell properties of human dental pulp stem cells. J Dent Res (2002) 5.57
HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol (2003) 5.35
Why are MSCs therapeutic? New data: new insight. J Pathol (2009) 5.25
Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood (2002) 5.14
Human mesenchymal stem cells modulate B-cell functions. Blood (2005) 5.12
Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood (2003) 4.09
Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg (2007) 4.00
Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev (2009) 3.73
Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells (2005) 3.36
Matrix cells from Wharton's jelly form neurons and glia. Stem Cells (2003) 2.95
Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng (2010) 2.66
Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS One (2009) 2.62
Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev (2012) 2.47
Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant (1995) 2.35
Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol (2002) 2.05
Isolation of multipotent cells from human term placenta. Stem Cells (2005) 2.03
Long-term survival of fat transplants: controlled demonstrations. Aesthetic Plast Surg (1996) 1.97
Mechanisms of mesenchymal stromal cell immunomodulation. Immunol Cell Biol (2012) 1.81
Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res (2000) 1.73
Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity. Stem Cells Int (2012) 1.63
Functional implications of CD34 expression in human adipose-derived stem/progenitor cells. Stem Cells Dev (2009) 1.53
Heterogeneity of mesenchymal stromal cell preparations. Cytotherapy (2008) 1.51
Native human adipose stromal cells: localization, morphology and phenotype. Int J Obes (Lond) (2011) 1.46
Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp Hematol (2003) 1.35
Human mesenchymal stem cells: from immunophenotyping by flow cytometry to clinical applications. Cytometry A (2012) 1.30
Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6. Cytotherapy (2009) 1.23
Adipose stem cell tissue-engineered construct used to treat large anterior mandibular defect: a case report and review of the clinical application of good manufacturing practice-level adipose stem cells for bone regeneration. J Oral Maxillofac Surg (2013) 1.23
GMP-level adipose stem cells combined with computer-aided manufacturing to reconstruct mandibular ameloblastoma resection defects: Experience with three cases. Ann Maxillofac Surg (2013) 1.22
Purification and properties of clostridiopeptidase B (Clostripain). J Biol Chem (1968) 1.14
Studies on the specificity of bacterial collagenase. Biochem Biophys Res Commun (1970) 1.10
A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment. Stem Cells Dev (2010) 1.08
Adipose tissue-derived mesenchymal stem cells facilitate hematopoiesis in vitro and in vivo: advantages over bone marrow-derived mesenchymal stem cells. Am J Pathol (2010) 1.06
An analysis of the role of collagenase and protease in the enzymatic dissociation of the rat pancreas for islet isolation. Diabetologia (1992) 1.05
Adipose-derived stem cells. Methods Mol Biol (2008) 1.00
Evidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells. PLoS One (2013) 0.99
In vitro differentiation of human skin-derived multipotent stromal cells into putative endothelial-like cells. BMC Dev Biol (2012) 0.95
Isolation of adipose tissue mesenchymal stem cells without tissue destruction: a non-enzymatic method. Tissue Cell (2013) 0.95
Enzymatic isolation of cells from bone: cytotoxic enzymes of bacterial collagenase. Am J Physiol (1981) 0.95
Reduced expression of distinct T-cell CD molecules by collagenase/DNase treatment. Cancer Immunol Immunother (1994) 0.94
Nonexpanded mesenchymal stem cells for regenerative medicine: yield in stromal vascular fraction from adipose tissues. Tissue Eng Part C Methods (2010) 0.93
A rapid and efficient method for primary culture of human adipose-derived stem cells. Organogenesis (2013) 0.89
Human mesenchymal stem cells: a bank perspective on the isolation, characterization and potential of alternative sources for the regeneration of musculoskeletal tissues. J Cell Physiol (2013) 0.88
Tissue dissociation enzymes for isolating human islets for transplantation: factors to consider in setting enzyme acceptance criteria. Transplantation (2011) 0.88
Isolation and expansion of synovial CD34(-)CD44(+)CD90(+) mesenchymal stem cells: comparison of an enzymatic method and a direct explant technique. Connect Tissue Res (2010) 0.86
Human adipose tissue stem cells: relevance in the pathophysiology of obesity and metabolic diseases and therapeutic applications. Expert Rev Mol Med (2012) 0.85
Xenofree enzymatic products for the isolation of human adipose-derived stromal/stem cells. Tissue Eng Part C Methods (2013) 0.83
Purification and characterization of three forms of collagenase from Clostridium histolyticum. Biochemistry (1984) 0.81
Interactions between mesenchymal stem cells and dendritic cells. Adv Biochem Eng Biotechnol (2013) 0.80
Trephine biopsies are enriched for activated T/NK cells and cytotoxic T cells. Immunol Lett (2005) 0.79
microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood (2009) 2.58
The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study. J Clin Oncol (2011) 2.38
Involved-field radiotherapy for advanced Hodgkin's lymphoma. N Engl J Med (2003) 2.35
Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells (2005) 2.30
Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial. J Clin Oncol (2012) 2.25
CD4⁺ follicular helper T cell infiltration predicts breast cancer survival. J Clin Invest (2013) 2.18
The Immunomodulatory Potential of Mesenchymal Stromal Cells: A Story of a Regulatory Network. J Immunother (2016) 2.14
Reduction of B cell turnover in chronic lymphocytic leukaemia. Br J Haematol (2008) 1.74
Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation. Differentiation (2004) 1.72
Human marrow mesenchymal stem cell culture: serum-free medium allows better expansion than classical alpha-MEM medium. Eur J Haematol (2006) 1.70
Radioembolization of the spleen: a revisited approach for the treatment of malignant lymphomatous splenomegaly. Cardiovasc Intervent Radiol (2012) 1.68
Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study. Stem Cells Dev (2009) 1.68
Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results. Blood (2007) 1.53
MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation. Blood (2012) 1.42
Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources. Cell Immunol (2010) 1.36
Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6. Cytotherapy (2009) 1.23
Gene expression pattern of functional neuronal cells derived from human bone marrow mesenchymal stromal cells. BMC Genomics (2008) 1.23
Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells. Hum Immunol (2010) 1.17
The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties. Cell Immunol (2011) 1.16
Ultrasonic low-energy treatment: a novel approach to induce apoptosis in human leukemic cells. Exp Hematol (2002) 1.14
Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. J Transl Med (2013) 1.11
Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia. Clin Chem (2007) 1.11
HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significance. Epigenetics (2012) 1.10
A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment. Stem Cells Dev (2010) 1.08
Bortezomib (PS-341, Velcade) increases the efficacy of trastuzumab (Herceptin) in HER-2-positive breast cancer cells in a synergistic manner. Mol Cancer Ther (2006) 1.07
High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial. J Clin Oncol (2013) 1.07
Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study. Cancer (2003) 1.05
Characterization and clinical evaluation of CD10+ stroma cells in the breast cancer microenvironment. Clin Cancer Res (2012) 1.03
Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo. Proc Natl Acad Sci U S A (2005) 1.02
Immune-related antigens, surface molecules and regulatory factors in human-derived mesenchymal stromal cells: the expression and impact of inflammatory priming. Stem Cell Rev (2012) 1.01
Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor. Tissue Eng Part A (2010) 1.01
Mesoderm-derived stem cells: the link between the transcriptome and their differentiation potential. Stem Cells Dev (2012) 1.00
Evidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells. PLoS One (2013) 0.99
Comparison of proposed diagnostic criteria with FACT-F and VAS for cancer-related fatigue: proposal for use as a screening tool. Support Care Cancer (2004) 0.99
Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells. Br J Haematol (2008) 0.97
In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues. Cytotherapy (2009) 0.96
Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes. Immunol Lett (2012) 0.95
Preemptive management of Epstein-Barr virus reactivation after hematopoietic stem-cell transplantation. Transplantation (2009) 0.95
Gene expression profiling reveals differences in microenvironment interaction between patients with chronic lymphocytic leukemia expressing high versus low ZAP70 mRNA. Haematologica (2009) 0.95
The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts. BMC Cancer (2010) 0.95